Question: is siponimod approved in canada?
Answer: Health Canada has approved Mayzent® (siponimod) for the treatment of adults with active secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features characteristic of multiple sclerosis inflammatory activity, to delay the progression of physical disability.